TipRanks
Go Ultimate55% OFF

Sisram Medical Ltd. (1696) Stock Price & Analysis

3 Followers

1696 Stock Chart & Stats

HK$1.77HK$0.01(0.57%)
At close: 4:00 PM GMT+8
HK$1.75HK$2HK$2.25Aug 10Aug 24Sep 7Sep 21Oct 5Oct 20Nov 2
Day’s Range
HKD 1.77 - HKD 1.88
52-Week Range
HKD 1.71 - HKD 4.91
Previous Close
HKD 1.76
Volume
N/A
Average Volume (3M)
232.39K
Market Cap
HKD 824.28M
Enterprise Value
HKD 2.01B
Total Cash (Recent Filing)
HKD 77.27M
Total Debt (Recent Filing)
HKD 78.87M
Price to Earnings (P/E)
9.3
Beta
0.99
Next Earnings
Mar 24, 2027 (Est.)
EPS Estimate
N/A
Dividend Yield
5.37%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage and continued equity growth give Sisram Medical financial resilience and flexibility. A conservative capital structure reduces balance-sheet risk, supports continued investment in products and services, and provides greater capacity to manage fluctuations in demand or profitability.

Recurring Installed-base Revenue

The installed-base model supplements one-time equipment sales with consumables, service, maintenance, and training revenue. As deployed systems are used over time, these recurring streams can improve customer retention, diversify revenue, and make the business less dependent on new capital-equipment purchases.

Revenue Growth And Gross Margin

Multi-year revenue growth indicates that Sisram Medical has continued expanding its business, while a gross margin near 59% shows meaningful economic value remains in its products. This combination can support reinvestment and operating leverage if growth and cost control improve.

Bears Say

Material Margin Compression

The sharp decline in net margin shows that revenue growth is currently converting into substantially less profit than in earlier periods. Higher costs and/or pricing pressure could remain a durable constraint, reducing reinvestment capacity and weakening earnings resilience even if sales continue to expand.

Weakened Cash Generation

The steep 2025 decline in operating and free cash flow indicates weaker cash conversion and reduces internally generated funding for growth, dividends, or investment. Although free cash flow remained positive, the deterioration raises concern that earnings are not translating consistently into available cash.

Declining Earnings Momentum

A substantial decline in EPS, alongside lower return on equity, signals that the company is currently generating less shareholder profit from its capital base. If this persists, it can limit the effectiveness of the strong balance sheet and weaken the sustainability of future earnings growth.

Sisram Medical Ltd. News

1696 FAQ

What was Sisram Medical Ltd.’s price range in the past 12 months?
Sisram Medical Ltd. lowest stock price was HK$1.71 and its highest was HK$4.91 in the past 12 months.
What is Sisram Medical Ltd.’s market cap?
Sisram Medical Ltd.’s market cap is HK$824.28M.
When is Sisram Medical Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Sisram Medical Ltd.’s earnings last quarter?
Sisram Medical Ltd. released its earnings results on Aug 19, 2026. The company reported -HK$0.02 earnings per share for the quarter.
Is Sisram Medical Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Sisram Medical Ltd. pay dividends?
Sisram Medical Ltd. pays a Annually dividend of HK$0.095 which represents an annual dividend yield of 5.37%. See more information on Sisram Medical Ltd. dividends here
What is Sisram Medical Ltd.’s EPS estimate?
Sisram Medical Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sisram Medical Ltd. have?
Sisram Medical Ltd. has 468,343,080 shares outstanding.
What happened to Sisram Medical Ltd.’s price movement after its last earnings report?
Sisram Medical Ltd. reported an EPS of -HK$0.02 in its last earnings report. Following the earnings report the stock price went down -2.729%.
Which hedge fund is a major shareholder of Sisram Medical Ltd.?
Currently, no hedge funds are holding shares in HK:1696
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology